← 返回

微流控辅助制备载 NK 细胞微凝胶增强肿瘤免疫治疗疗效

英文原题:Microfluidics-assisted fabrication of natural killer cell-laden microgel enhances the therapeutic efficacy for tumor immunotherapy.

查看英文原题

Microfluidics-assisted fabrication of natural killer cell-laden microgel enhances the therapeutic efficacy for tumor immunotherapy.

PubMed 2024/04/17(内容时间) Mater Today Bio Q1 · IF 11(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

近年来,相较于化疗或靶向治疗等传统抗癌疗法,人们对癌症免疫治疗的兴趣日益增加。自然杀伤(NK)细胞是免疫细胞家族的一部分,在肿瘤免疫治疗中至关重要,因为它们能够检测并杀死癌细胞。

然而,NK细胞的缺点是细胞培养困难。在本研究中,利用微流控通道制备了多孔微凝胶,以有效培养NK细胞。使用微流控制备微凝胶可以在短时间内大规模生产,并且可以制成均匀的尺寸。微凝胶由光交联聚合物如甲基丙烯酸明胶(GelMa)组成,并可通过控制GelMa浓度进行调节。与二维(2D)培养相比,负载NK92细胞的三维(3D)微凝胶增加了mRNA表达水平、NK92细胞增殖、细胞因子释放和抗肿瘤疗效。

此外,该研究证实,在K562白血病小鼠模型中,与2D培养的NK92细胞相比,3D培养的NK92细胞增强了抗肿瘤效果。含有健康NK细胞的微凝胶被设计为在5天后完全降解,使NK细胞得以释放,从而实现与癌细胞的细胞间相互作用。

总体而言,该微凝胶系统为有效培养NK细胞提供了一种新的细胞培养平台,并为开发免疫细胞治疗提供了一种新策略。

展开英文摘要原文

Recently, interest in cancer immunotherapy has increased over traditional anti-cancer therapies such as chemotherapy or targeted therapy. Natural killer (NK) cells are part of the immune cell family and essential to tumor immunotherapy as they detect and kill cancer cells.

However, the disadvantage of NK cells is that cell culture is difficult. In this study, porous microgels have been fabricated using microfluidic channels to effectively culture NK cells. Microgel fabrication using microfluidics can be mass-produced in a short time and can be made in a uniform size.

Microgels consist of photo cross-linkable polymers such as methacrylic gelatin (GelMa) and can be regulated via controlled GelMa concentrations. NK92 cell-laden three-dimensional (3D) microgels increase mRNA expression levels, NK92 cell proliferation, cytokine release, and anti-tumor efficacy, compared with two-dimensional (2D) cultures.

In addition, the study confirms that 3D-cultured NK92 cells enhance anti-tumor effects compared with enhancement by 2D-cultured NK92 cells in the K562 leukemia mouse model. Microgels containing healthy NK cells are designed to completely degrade after 5 days allowing NK cells to be released to achieve cell-to-cell interaction with cancer cells.

Overall, this microgel system provides a new cell culture platform for the effective culturing of NK cells and a new strategy for developing immune cell therapy.

论文信息

作者
Lee D、Kim SM、Kim D、Baek SY、Yeo SJ、Lee JJ、Cha C、Park SA
单位
Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.South Korea
期刊
Materials today. Bio2024 Jun
原文标识
PubMed 38693995 · DOI 10.1016/j.mtbio.2024.101055